OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors Written by PR Newswire Enable JavaScript and cookies to continueRead more http://www.prnasia.com/story/archive/5026733_AE26733_0